Finance

Beta
Lists
DMAAU:NASDAQ
Drugs Made In America Acquisition Units
10,61 USD
-0,66%
(-0,070) 1D
17-июн., 15:31:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAAU...
Mkt. cap
258,06 млн
Avg. vol.
1,45 миң
Volume
0,00
52-wk high
12,50 USD
52-wk low
10,30 USD
Shares outstanding
23,03 млн
Mkt. cap
258,06 млн
Avg. vol.
1,45 миң
Volume
0,00
52-wk high
12,50 USD
52-wk low
10,30 USD
Shares outstanding
23,03 млн
News stories
From sources across the web
About Drugs Made In America Acquisition Units
CEO-
Employees-
Founded2024
Headquarters-
SectorCapital market
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
131,92 миң
263,70 миң
2,09 млн
143,30 миң
Operating expense
131,92 миң
263,70 миң
2,09 млн
143,30 миң
Total operating expenses
131,92 миң
263,70 миң
2,09 млн
143,30 миң
Operating income
-131,92 миң
-263,70 миң
-2,09 млн
-143,30 миң
Other non operating income
-
-
-
-
EBT including unusual items
2,29 млн
2,18 млн
212,96 миң
1,97 млн
EBT excluding unusual items
2,29 млн
2,18 млн
212,96 миң
1,97 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
2,29 млн
2,18 млн
212,96 миң
1,97 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,42 млн
2,45 млн
2,30 млн
2,11 млн
Interest expense
-
-
-
-
Net interest expenses
2,42 млн
2,45 млн
2,30 млн
2,11 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more